Advanced searchCitation search
Skip main navigation
Close Drawer MenuOpen Drawer Menu
Reviews7 January 2014

Opioid Prescribing: A Systematic Review and Critical Appraisal of Guidelines for Chronic Pain

    Author, Article, and Disclosure Information
    https://doi.org/10.7326/0003-4819-160-1-201401070-00732
    Background:

    Deaths due to prescription opioid overdoses have increased dramatically. High-quality guidelines could help clinicians mitigate risks associated with opioid therapy.

    Purpose:

    To evaluate the quality and content of guidelines on the use of opioids for chronic pain.

    Data Sources:

    MEDLINE, National Guideline Clearinghouse, specialty society Web sites, and international guideline clearinghouses (searched in July 2013).

    Study Selection:

    Guidelines published between January 2007 and July 2013 addressing the use of opioids for chronic pain in adults were selected. Guidelines on specific settings, populations, and conditions were excluded.

    Data Extraction:

    Guidelines and associated systematic reviews were evaluated using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument and A Measurement Tool to Assess Systematic Reviews (AMSTAR), respectively, and recommendations for mitigating opioid-related risks were compared.

    Data Synthesis:

    Thirteen guidelines met selection criteria. Overall AGREE II scores were 3.00 to 6.20 (on a scale of 1 to 7). The AMSTAR ratings were poor to fair for 10 guidelines. Two received high AGREE II and AMSTAR scores. Most guidelines recommend that clinicians avoid doses greater than 90 to 200 mg of morphine equivalents per day, have additional knowledge to prescribe methadone, recognize risks of fentanyl patches, titrate cautiously, and reduce doses by at least 25% to 50% when switching opioids. Guidelines also agree that opioid risk assessment tools, written treatment agreements, and urine drug testing can mitigate risks. Most recommendations are supported by observational data or expert consensus.

    Limitation:

    Exclusion of non–English-language guidelines and reliance on published information.

    Conclusion:

    Despite limited evidence and variable development methods, recent guidelines on chronic pain agree on several opioid risk mitigation strategies, including upper dosing thresholds; cautions with certain medications; attention to drug–drug and drug–disease interactions; and use of risk assessment tools, treatment agreements, and urine drug testing. Future research should directly examine the effectiveness of opioid risk mitigation strategies.

    Primary Funding Source:

    California Department of Industrial Relations and California Commission on Health and Safety and Workers’ Compensation.

    References

    • 1. Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. NCHS Data Brief. 2009;:1-8. [PMID: 19796521] MedlineGoogle Scholar
    • 2. Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA. 2008;299:70-8. [PMID: 18167408] CrossrefMedlineGoogle Scholar
    • 3. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18:1166-75. [PMID: 19718704] CrossrefMedlineGoogle Scholar
    • 4. Franklin GM, Mai J, Turner J, Sullivan M, Wickizer T, Fulton-Kehoe D. Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline. Am J Ind Med. 2012;55:325-31. [PMID: 22213274] CrossrefMedlineGoogle Scholar
    • 5. Quality improvement guidelines for the treatment of acute pain and cancer pain. JAMA. 1995;274:1874-80. [PMID: 7500539] CrossrefMedlineGoogle Scholar
    • 6. The Joint Commission. Facts about Pain Management. Oakbrook Terrace, IL: The Joint Commission; 2012. Accessed at www.jointcommission.org/pain_management on 9 March 2012. Google Scholar
    • 7. Katz LY, Cox BJ, Clara IP, Oleski J, Sacevich T. Substance abuse versus dependence and the structure of common mental disorders. Compr Psychiatry. 2011;52:638-43. [PMID: 21295775] CrossrefMedlineGoogle Scholar
    • 8. Dembe A, Wickizer T, Sieck C, Partridge J, Balchick R. Opioid use and dosing in the workers' compensation setting. A comparative review and new data from Ohio. Am J Ind Med. 2012;55:313-24. [PMID: 22068830] CrossrefMedlineGoogle Scholar
    • 9. Becker WC, Tobin DG, Fiellin DA. Nonmedical use of opioid analgesics obtained directly from physicians: prevalence and correlates. Arch Intern Med. 2011;171:1034-6. [PMID: 21670373] CrossrefMedlineGoogle Scholar
    • 10. Murphy SL, Xu J, Kochanek KD; Division of Vital Statistics. Deaths: Preliminary Data for 2010. National Vital Statistics Reports. Hyattsville, MD: U.S. Department of Health and Human Services; 2012. Google Scholar
    • 11. Office of National Drug Control Policy. Prescription Drug Abuse. Washington, DC: The White House; 2012. Accessed at www.whitehouse.gov/ondcp/prescription-drug-abuse on 11 May 2013. Google Scholar
    • 12. Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: National Academies Pr; 2011. Google Scholar
    • 13. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113-30. [PMID: 19187889] CrossrefMedlineGoogle Scholar
    • 14. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;:CD006605. [PMID: 20091598] MedlineGoogle Scholar
    • 15. Campbell CI, Weisner C, Leresche L, Ray GT, Saunders K, Sullivan MD, et al. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health. 2010;100:2541-7. [PMID: 20724688] CrossrefMedlineGoogle Scholar
    • 16. American Medical Association. National Medical Specialty Society Websites. Chicago: American Medical Assoc; 2012. Accessed at www.ama-assn.org/ama/pub/about-ama/our-people/the-federation-medicine/national-medical-specialty-society-websites.page on 12 April 2012. Google Scholar
    • 17. Washington State Department of Labor & Industries. Medical Treatment Guidelines. Tumwater, WA: Washington State Department of Labor & Industries; 2012. Accessed at www.lni.wa.gov/claimsins/providers/treatingpatients/treatguide on 12 August 2012. Google Scholar
    • 18. California Division of Workers' Compensation. Medical Treatment Schedule. Chronic Pain Medical Treatment Guidelines. Sacramento, CA: California Division of Workers' Compensation; 2009. Accessed at www.coa.org/Saturday/sat13stevenfeinbergmdhandout1.pdf on 24 August 2012. Google Scholar
    • 19. Colorado Division of Workers' Compensation. Chronic Pain Disorder Medical Treatment Guidelines. Denver: Colorado Division of Workers' Compensation; 2011. Accessed at www.colorado.gov/cs/Satellite?c=Page&childpagename=CDLE-WorkComp%2FCDLELayout&cid=1251634346702&pagename=CDLEWrapper on 1 August 2013. Google Scholar
    • 20. Guidelines International Network Web site. Accessed at www.g-i-n.net on 1 August 2013. Google Scholar
    • 21. National Institute for Health and Care Excellence Web site. Accessed at www.nice.org.uk on 1 August 2013. Google Scholar
    • 22. Canadian Medical Association. CMA Infobase Web site. Accessed at www.cma.ca/clinicalresources/practiceguidelines on 1 August 2013. Google Scholar
    • 23. Australian Government National Health and Medical Research Council. Clinical Practice Guidelines Portal Web site. Accessed at www.clinicalguidelines.gov.au on 1 August 2013. Google Scholar
    • 24. Australian Government National Health and Medical Research Council. Guidelines and Publication Search Web site. Accessed at www.nhmrc.gov.au/guidelines/publications on 1 August 2013. Google Scholar
    • 25. Scottish Intercollegiate Guidelines Network Web site. Accessed at www.sign.ac.uk/guidelines/published/index.html on 1 August 2013. Google Scholar
    • 26. New Zealand Ministry of Health. New Zealand Guidelines Group Web site. Accessed at www.health.govt.nz/about-ministry/ministry-health-websites/new-zealand-guidelines-group on 1 August 2013. Google Scholar
    • 27. Biblioteca de Guías de Práctica Clínica del Sistema Nacional de Salud (Library of Clinical Practice Guidelines from the National Health System) Web site. Accessed at www.guiasalud.es/web/guest/gpc-sns on 1 August 2013. Google Scholar
    • 28. Agency for Quality in Medicine. AQuMed Database Web site. Accessed at www.aezq.de/aezq/publications on 1 August 2013. Google Scholar
    • 29. National Disease Management Guidelines Programme. German Disease Management Guidelines. Berlin, Germany: National Disease Management Guidelines Programme; 2012. Accessed at www.versorgungsleitlinien.de/english/index_html on 1 August 2013. Google Scholar
    • 30. European Medicines Agency. Document Library. London: European Medicines Agency; 2013. Accessed at www.ema.europa.eu/ema/index.jsp?curl=pages/document_library/landing/document_library_search.jsp?= on 1 August 2013. Google Scholar
    • 31. British Columbia Ministry of Health. BCGuidelines Web site. Accessed at www.bcguidelines.ca/alphabetical.html on 1 August 2013. Google Scholar
    • 32. Institute of Medicine. Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Pr; 2011. Google Scholar
    • 33. Shekelle PG, Ortiz E, Rhodes S, Morton SC, Eccles MP, Grimshaw JM, et al. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated? JAMA. 2001;286:1461-7. [PMID: 11572738] CrossrefMedlineGoogle Scholar
    • 34. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al; AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182:839-42. [PMID: 20603348] CrossrefMedlineGoogle Scholar
    • 35. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al; AGREE Next Steps Consortium. Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ. 2010;182:1045-52. [PMID: 20513780] CrossrefMedlineGoogle Scholar
    • 36. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al; AGREE Next Steps Consortium. Development of the AGREE II, part 2: assessment of validity of items and tools to support application. CMAJ. 2010;182:472-8. [PMID: 20513779] CrossrefMedlineGoogle Scholar
    • 37. Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansson E, Grimshaw J, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol. 2009;62:1013-20. [PMID: 19230606] CrossrefMedlineGoogle Scholar
    • 38. AGREE Enterprise Web site. Accessed at www.agreetrust.org on 22 May 2013. Google Scholar
    • 39. Nuckols TK, Diamant AL, Popescu I, Anderson L, Chou R. Report to The California Department of Industrial Relations and The California Commission on Health and Safety and Workers' Compensation: Identifying Risky Opioid Prescribing Practices. Los Angeles: Univ of California, Los Angeles; 2012. Google Scholar
    • 40. British Pain Society. Opioids for Persistent Pain: Good Practice. London: British Pain Society; 2010. Accessed at www.britishpainsociety.org/book_opioid_main.pdf on 1 August 2013. Google Scholar
    • 41. Health Care Association of New Jersey. Pain Management Guideline. Hamilton, NJ: Health Care Assoc of New Jersey; 2006. Accessed at www.hcanj.org/docs/hcanjbp_painmgmt2.pdf on 1 August 2013. Google Scholar
    • 42. Ho KY, Chua NH, George JM, Yeo SN, Main NB, Choo CY, et al. Evidence-based guidelines on the use of opioids in chronic non-cancer pain—a consensus statement by the Pain Association of Singapore Task Force. Ann Acad Med Singapore. 2013;42:138-52. [PMID: 23604503] MedlineGoogle Scholar
    • 43. Drug and Alcohol Services South Australia. Opioid Prescription in Chronic Pain Conditions. Guidelines for South Australian General Practitioners (GPs). Parkside, Australia: Drug and Alcohol Services South Australia; 2008. Accessed at www.dassa.sa.gov.au/webdata/resources/files/Opioid_prescription_chronic_pain_guidelines_for_SA_GPs.pdf on 1 August 2013. Google Scholar
    • 44. Berland DW, Rodgers PE. Managing Chronic Non-Terminal Pain in Adults, Including Prescribing Controlled Substances. Ann Arbor, MI: Univ of Michigan Health System; 2012. Accessed at www.med.umich.edu/1info/FHP/practiceguides/pain/pain.pdf on 14 April 2012. Google Scholar
    • 45. Department of Veterans Affairs, Department of Defense. Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain. Washington, DC: Department of Defense; 2012. Accessed at www.healthquality.va.gov/cot/cot_310_sum.pdf on 14 April 2012. Google Scholar
    • 46. Furlan AD, Reardon R, Weppler C; National Opioid Use Guideline Group. Opioids for chronic noncancer pain: a new Canadian practice guideline. CMAJ. 2010;182:923-30. [PMID: 20439443] CrossrefMedlineGoogle Scholar
    • 47. Institute for Clinical Systems Improvement. Assessment and Management of Chronic Pain. Bloomington, MN: Institute for Clinical Systems Improvement; 2011. Accessed at www.icsi.org/_asset/bw798b/ChronicPain.pdf on 14 April 2012. Google Scholar
    • 48. Rolfs RT, Johnson E, Williams NJ, Sundwall DN; Utah Department of Health. Utah clinical guidelines on prescribing opioids for treatment of pain. J Pain Palliat Care Pharmacother. 2010;24:219-35. [PMID: 20718642] CrossrefMedlineGoogle Scholar
    • 49. Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, et al; American Society of Interventional Pain Physicians. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2—guidance. Pain Physician. 2012;15:S67-116. [PMID: 22786449] MedlineGoogle Scholar
    • 50. Utah Department of Health. Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain. Salt Lake City, UT: Utah Department of Health; 2009. Google Scholar
    • 51. AGS Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc. 2002;50:S205-24. [PMID: 12067390] CrossrefMedlineGoogle Scholar
    • 52. American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57:1331-46. [PMID: 19573219] CrossrefMedlineGoogle Scholar
    • 53. American Society of Anesthesiologists Task Force on Chronic Pain Management. Practice guidelines for chronic pain management: an updated report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine. Anesthesiology. 2010;112:810-33. [PMID: 20124882] CrossrefMedlineGoogle Scholar
    • 54. Fine PG, Portenoy RK; Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation. Establishing “best practices” for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage. 2009;38:418-25. [PMID: 19735902] CrossrefMedlineGoogle Scholar
    • 55. American College of Occupational and Environmental Medicine. ACOEM Guidelines for Chronic Use of Opioids. Elk Grove Village, IL: American Coll of Occupational and Environmental Medicine; 2008. Accessed at www.acoem.org/Guidelines_Opioids.aspx on 13 March 2012. Google Scholar
    • 56. Work Loss Data Institute. Pain (chronic). Encinitas, CA: Work Loss Data Institute; 2011. Google Scholar
    • 57. American Pain Society, American Academy of Pain Medicine. Guideline for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain: Evidence Review. Chicago: American Pain Soc; 2009. Accessed at www.americanpainsociety.org/uploads/pdfs/Opioid_Final_Evidence_Report.pdf on 30 April 2013. Google Scholar
    • 58. Chou R. 2009 Clinical guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice? Pol Arch Med Wewn. 2009;119:469-77. [PMID: 19776687] MedlineGoogle Scholar
    • 59. Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, et al; American Society of Interventional Pain Physicians. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I—evidence assessment. Pain Physician. 2012;15:S1-65. [PMID: 22786448] CrossrefMedlineGoogle Scholar
    • 60. National Opioid Use Guideline Group. Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain. Hamilton, Ontario, Canada: National Pain Centre; 2010. Accessed at http://nationalpaincentre.mcmaster.ca/opioid on 13 April 2012. Google Scholar
    • 61. Kahan M, Mailis-Gagnon A, Wilson L, Srivastava A; National Opioid Use Guideline Group. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population. Can Fam Physician. 2011;57:1257-66, e407-18. [PMID: 22084455] MedlineGoogle Scholar
    • 62. Kahan M, Wilson L, Mailis-Gagnon A, Srivastava A; National Opioid Use Guideline Group. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations. Can Fam Physician. 2011;57:1269-76, e419-28. [PMID: 22084456] MedlineGoogle Scholar
    • 63. U.S. Food and Drug Administration. FDA Public Health Advisory: Important Information for the Safe Use of Fentanyl Transdermal System (Patch). Silver Spring, MD: U.S. Food and Drug Administration; 2007. Accessed at www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm051257.htm on 27 April 2013. Google Scholar
    • 64. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112:65-75. [PMID: 15494186] CrossrefMedlineGoogle Scholar
    • 65. Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain. 2008;9:360-72. [PMID: 18203666] CrossrefMedlineGoogle Scholar
    • 66. Passik SD, Kirsh KL. An opioid screening instrument: long-term evaluation of the utility of the pain medication questionnaire by Holmes et al [Editorial]. Pain Pract. 2006;6:69-71. [PMID: 17309712] CrossrefMedlineGoogle Scholar
    • 67. Passik SD, Kirsh KL, Whitcomb L, Portenoy RK, Katz NP, Kleinman L, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004;26:552-61. [PMID: 15189752] CrossrefMedlineGoogle Scholar
    • 68. Butler SF, Budman SH, Fernandez KC, Houle B, Benoit C, Katz N, et al. Development and validation of the Current Opioid Misuse Measure. Pain. 2007;130:144-56. [PMID: 17493754] CrossrefMedlineGoogle Scholar
    • 69. Centers for Disease Control and Prevention (CDC). CDC grand rounds: prescription drug overdoses—a U.S. epidemic. MMWR Morb Mortal Wkly Rep. 2012;61:10-3. [PMID: 22237030] MedlineGoogle Scholar
    • 70. Harris SR, Schmitz KH, Campbell KL, McNeely ML. Clinical practice guidelines for breast cancer rehabilitation: syntheses of guideline recommendations and qualitative appraisals. Cancer. 2012;118:2312-24. [PMID: 22488705] CrossrefMedlineGoogle Scholar
    • 71. Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012;52:930-45. [PMID: 22671714] CrossrefMedlineGoogle Scholar
    • 72. Burda BU, Norris SL, Holmer HK, Ogden LA, Smith ME. Quality varies across clinical practice guidelines for mammography screening in women aged 40-49 years as assessed by AGREE and AMSTAR instruments. J Clin Epidemiol. 2011;64:968-76. [PMID: 21420280] CrossrefMedlineGoogle Scholar
    • 73. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458-65. [PMID: 10535437] CrossrefMedlineGoogle Scholar
    • 74. Chan W. Implementation of GLIA assessment in Kaiser Permanente and NHLBI to improve implementability of recommendations. Otolaryngol Head Neck Surg. 2010;143:59.1. CrossrefGoogle Scholar
    • 75. Gupta S, Bhattacharyya OK, Brouwers MC, Estey EA, Harrison MB, Hernandez P, et al. Canadian Thoracic Society: Presenting a new process for clinical practice guideline production. Can Respir J. 2009;16:62-8. [PMID: 20011719] CrossrefMedlineGoogle Scholar
    • 76. van Dijk LJ, Nelen WL, D'Hooghe TM, Dunselman GA, Hermens RP, Bergh C, et al. The European Society of Human Reproduction and Embryology guideline for the diagnosis and treatment of endometriosis: an electronic guideline implementability appraisal. Implement Sci. 2011;6:7. [PMID: 21247418] CrossrefMedlineGoogle Scholar
    • 77. GuideLine Implementability Appraisal Web site. Accessed at http://nutmeg.med.yale.edu/glia/login.htm;jsessionid=C839F08F4060F49D3F86DF9D7A749BA on 6 September 2012. Google Scholar
    • 78. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315-21. [PMID: 21467284] CrossrefMedlineGoogle Scholar
    • 79. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152:85-92. [PMID: 20083827] LinkGoogle Scholar
    • 80. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171:686-91. [PMID: 21482846] CrossrefMedlineGoogle Scholar
    • 81. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174:1589-94. [PMID: 16717269] CrossrefMedlineGoogle Scholar
    • 82. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372-80. [PMID: 15561393] CrossrefMedlineGoogle Scholar
    • 83. Papaleontiou M, Henderson CR, Turner BJ, Moore AA, Olkhovskaya Y, Amanfo L, et al. Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis. J Am Geriatr Soc. 2010;58:1353-69. [PMID: 20533971] CrossrefMedlineGoogle Scholar
    • 84. Manchikanti L, Ailinani H, Koyyalagunta D, Datta S, Singh V, Eriator I, et al. A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain. Pain Physician. 2011;14:91-121. [PMID: 21412367] CrossrefMedlineGoogle Scholar
    • 85. Noble M, Tregear SJ, Treadwell JR, Schoelles K. Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage. 2008;35:214-28. [PMID: 18178367] CrossrefMedlineGoogle Scholar
    • 86. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008;9:444-59. [PMID: 18489635] CrossrefMedlineGoogle Scholar
    • 87. Washington State Agency Medical Directors' Group. Interagency Guideline on Opioid Dosing for Chronic Non-Cancer Pain: An Educational Aid to Improve Care and Safety With Opioid Therapy. Olympia, WA: Washington State Agency Medical Directors' Group; 2010. Accessed at www.agencymeddirectors.wa.gov/Files/OpioidGdline.pdf on 14 April 2012. Google Scholar
    • 88. Nuckols TK, Lim YW, Wynn BO, Mattke S, MacLean CH, Harber P, et al. Rigorous development does not ensure that guidelines are acceptable to a panel of knowledgeable providers. J Gen Intern Med. 2008;23:37-44. [PMID: 18030541] CrossrefMedlineGoogle Scholar
    Previous
    Next

    Submit a Comment

    Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
    *All comments submitted after October 1, 2021 and selected for publication will be published online only.
    Cancel